All In MedTech

Device Trial Radar · NCT05381961

Observational Study of BIS in Hemodialysis Patients

Observational Study of Bioimpedance Spectroscopy (BIS) for Use in a Renal Population

Last checked: Nov 20, 2026Latest source record: Sep 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

70

Planned (sponsor's estimate)

Start

Apr 4, 2022

Primary completion

Nov 8, 2022

Study completion Sep 2023

Sponsor

Lead sponsor
ImpediMed LimitedNot on our public-company list
Sponsor type
Industry
Collaborators
California Institute of Renal Research; Frenova Renal Research
First posted
May 19, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This observational study will evaluate bioimpedance spectroscopy (BIS) measurements from patients undergoing hemodialysis.

Conditions

  • Kidney Failure, Chronic
  • Renal Failure Chronic
  • Hemodialysis

Interventions

  • Bioimpedance spectroscopy (BIS) measurement, SOZO deviceDevice

    All patients enrolled in this study will undergo BIS measurement before and after 12 hemodialysis sessions (pre-dialysis and post-dialysis BIS measurements for each session). Measurements are not provided to treating physicians and are not used to guide clinical decisions; i.e., BIS measurements are collected for observational purposes only.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. BIS correlation with amount of fluid dialyzedTime frame: 12 hemodialysis sessions (over 4 to 6 weeks)

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Balboa Research - Kearny Mesa

    San Diego, California

  • Balboa Research - Rancho Bernardo

    San Diego, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.